| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | US20080166359 Anticancer agents; mitogen-activated protein kinases (MEK) |
| 07/10/2008 | US20080166358 Quinazoline derivatives and methods of treatment |
| 07/10/2008 | US20080166357 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6) |
| 07/10/2008 | US20080166355 Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon |
| 07/10/2008 | US20080166351 Kit comprising beacizumab and antitumor agents for use in treatment of metastatic colorectal cancer in a human |
| 07/10/2008 | US20080166349 Method to Inhibit the Propagation of an Undesired Cell Population |
| 07/10/2008 | US20080166344 Coadministration of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide and carboplatin; kits |
| 07/10/2008 | US20080166340 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapeutics and cancer |
| 07/10/2008 | US20080166339 Inhibition of osteopontin for treatment of relapsing autoimmune disease |
| 07/10/2008 | US20080166337 Nucleotide sequences coding tumor associated differentially-expressed gene-12 (TADG-12) protein (serine protease) for use as tool in tissue targeted cancer therapy |
| 07/10/2008 | US20080166332 Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors |
| 07/10/2008 | US20080166330 Bacterial Compositions For Prevention Or Treatment Of Atherosclerotic Disorders |
| 07/10/2008 | US20080166323 Activators of Hexosamine Biosynthesis as Inhibitors of Injury Induced by Ischemia or Hermorrhagic Shock |
| 07/10/2008 | US20080166318 Methods and therapeutic combinations for the treatment of demyelination |
| 07/10/2008 | US20080166316 For use on the skin includes a carbomer, a starch, vitamins, moisturizers, an astringent, a Pluronic, dimethicone, and an aluminum compound (aluminum acetate); compatible with the use of gloves, including latex gloves |
| 07/10/2008 | US20080166310 Administration of 2-oxyacetamide compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting the depigmentation and/or bleaching thereof |
| 07/10/2008 | US20080166304 Contacting the microorganism with a phenothiazinium and a microbial MDR inhibitor and irradiating the phenothiazinium producing a phototoxic species that inactivates the microorganism |
| 07/10/2008 | US20080166301 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; osteoporosis; endometriosis; benign prostatic hyperplasia; cardiovascular disorders; acne |
| 07/10/2008 | US20080166299 Prevent accumulation of amyloid deposits |
| 07/10/2008 | US20080166298 6- (2, 3, 4, 5-Tetrahydro-1H-Benzo [D] Azepin-7-Yloxy) -Nicotamide Derivatives as Radio Labelled Ligands |
| 07/10/2008 | US20080166296 Pharmaceutical Gallium Compositions and Methods |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 07/10/2008 | DE102007002073A1 Medium for use during care and antimicrobial treatment of skin, for topical dermatological application, and for therapeutic skin and sore treatment, comprises benzalkonium chloride, which is basically exclusive pharmaceutically active |
| 07/10/2008 | DE102007001198A1 Reducing anomer of a spectinomycin, useful in veterinary medical antibiotic, comprises providing a substance comprising spectinomycin, spectinomycin-salts, spectinomycin salt-hydrate and contaminating anomer and autoclaving the substance |
| 07/10/2008 | CA2711003A1 Targeting of ews-fli1 as anti-tumor therapy |
| 07/10/2008 | CA2710051A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2674671A1 Combination product for controlling parasites on animals |
| 07/10/2008 | CA2674669A1 Agents for controlling parasites on animals |
| 07/10/2008 | CA2674550A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 07/10/2008 | CA2674455A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674360A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674358A1 Crystalline forms of solvated ilaprazole |
| 07/10/2008 | CA2674355A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674348A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674347A1 Solid state forms of racemic ilaprazole |
| 07/10/2008 | CA2674302A1 Methods of use for cyclopamine analogs |
| 07/10/2008 | CA2674237A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | CA2674209A1 Glp-1 pharmaceutical compositions |
| 07/10/2008 | CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | CA2674178A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | CA2674162A1 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors |
| 07/10/2008 | CA2674154A1 Azaspiro derivatives |
| 07/10/2008 | CA2674144A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
| 07/10/2008 | CA2674141A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/10/2008 | CA2674133A1 Indoles |
| 07/10/2008 | CA2674093A1 Piperidine gpcr agonists |
| 07/10/2008 | CA2674084A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 07/10/2008 | CA2674080A1 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof |
| 07/10/2008 | CA2674063A1 Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin d analog with or withouta retinoid |
| 07/10/2008 | CA2674048A1 Cyclitols and their derivatives and their therapeutic applications |
| 07/10/2008 | CA2673995A1 Cyclopamine analogs |
| 07/10/2008 | CA2673976A1 Gel composition for treating mycosis |
| 07/10/2008 | CA2673974A1 Composition and methods for modulating a kinase cascade |
| 07/10/2008 | CA2673965A1 Pyrazolopyrimidine compound |
| 07/10/2008 | CA2673924A1 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | CA2673863A1 Methods and compositions for therapeutic treatment |
| 07/10/2008 | CA2673809A1 Thioxanthene derivates useful to treat infectious diseases |
| 07/10/2008 | CA2673776A1 Compounds and pharmaceutical compositions for the treatment of liver disorders |
| 07/10/2008 | CA2673722A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 07/10/2008 | CA2673667A1 Crystalline forms glyt1 |
| 07/10/2008 | CA2673584A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | CA2673580A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | CA2673513A1 Inhibition of ppar gamma expression by specific osteogenic oxysterols |
| 07/10/2008 | CA2673506A1 Antibacterial compounds and processes for its production |
| 07/10/2008 | CA2673428A1 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 07/10/2008 | CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | CA2673232A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | CA2672960A1 Novel jnk inhibitors |
| 07/10/2008 | CA2672940A1 Novel jnk inhibitors |
| 07/10/2008 | CA2672933A1 Method of treating cancer by a combined therapy of anticancer agents |
| 07/10/2008 | CA2672888A1 Methods and formulations for improved bioavailability of antiprogestins |
| 07/10/2008 | CA2672886A1 Transport molecules using reverse sequence hiv-tat polypeptides |
| 07/10/2008 | CA2672868A1 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | CA2672860A1 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | CA2672725A1 Heterocycle substituted heteroaryl compounds as receptor agonists for the treatment of diabetes and metabolic disorders |
| 07/10/2008 | CA2672538A1 Pharmaceutical compositions of alkyl gallates |
| 07/10/2008 | CA2672534A1 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 07/10/2008 | CA2672420A1 Methods for enhancing exercise performance |
| 07/10/2008 | CA2672207A1 Methods and compositions for repelling arthropods |
| 07/10/2008 | CA2671710A1 Conglomerates of tenatoprazole potassium salts |
| 07/10/2008 | CA2671209A1 Use of adenosine deaminase for treating pulmonary disease |
| 07/10/2008 | CA2670658A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | CA2669821A1 2-aza-bicyclo[3.1.0]hexane derivatives |
| 07/10/2008 | CA2668738A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | CA2643679A1 Immune response modifier formulations containing oleic acid and methods |
| 07/09/2008 | EP1942197A1 Method for determining the methylation degree of certain cytosines in genome DNA in the sequence context 5'-CpG-3' |
| 07/09/2008 | EP1942109A1 Taxane compound with azetidine ring structure |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1942106A1 Therapeutic agents useful for treating pain |
| 07/09/2008 | EP1942105A1 Aminodihydrothiazine derivative |
| 07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1942100A1 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 07/09/2008 | EP1942093A1 Novel cyclohexenone compounds from antrodia camphorata and application thereof |
| 07/09/2008 | EP1941911A1 Method for prevention and/or treatment of rheumatoid arthritis |